Literature DB >> 33333127

Diversity of Mechanisms Underlying Latent TGF-β Activation in Recessive Dystrophic Epidermolysis Bullosa.

Eijiro Akasaka1, Svenja Kleiser2, Gerhard Sengle3, Leena Bruckner-Tuderman1, Alexander Nyström4.   

Abstract

Injury- and inflammation-driven progressive dermal fibrosis is a severe manifestation of recessive dystrophic epidermolysis bullosa-a genetic skin blistering disease caused by mutations in COL7A1. TGF-β activation plays a prominent part in progressing dermal fibrosis. However, the underlying mechanisms are not fully elucidated. TGF-β is secreted in a latent form, which has to be activated for its biological functions. In this study, we determined that recessive dystrophic epidermolysis bullosa fibroblasts have an enhanced capacity to activate the latent form. Mechanistic and functional assessment demonstrated that this process depends on multiple latent TGF-β activators, including TSP-1, RGD-binding integrins, matrix metalloproteinases, and ROS, which act in concert, in a self-perpetuating feedback loop to progress fibrosis. Importantly, our study also disclosed keratinocytes as prominent facilitators of fibrosis in recessive dystrophic epidermolysis bullosa. They stimulate microenvironmental latent TGF-β activation through enhanced production of the above mediators. Collectively, our study provides data on the molecular mechanism behind dysregulated TGF-β signaling in recessive dystrophic epidermolysis bullosa, which are much needed for the development of evidence-based fibrosis-delaying treatments.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 33333127     DOI: 10.1016/j.jid.2020.10.024

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  4 in total

1.  hTERT-Driven Immortalization of RDEB Fibroblast and Keratinocyte Cell Lines Followed by Cre-Mediated Transgene Elimination.

Authors:  Nadezhda A Evtushenko; Arkadii K Beilin; Erdem B Dashinimaev; Rustam H Ziganshin; Anastasiya V Kosykh; Maxim M Perfilov; Alexandra L Rippa; Elena V Alpeeva; Andrey V Vasiliev; Ekaterina A Vorotelyak; Nadya G Gurskaya
Journal:  Int J Mol Sci       Date:  2021-04-07       Impact factor: 5.923

Review 2.  Bioengineered Efficacy Models of Skin Disease: Advances in the Last 10 Years.

Authors:  Diana Nicole Stanton; Gitali Ganguli-Indra; Arup Kumar Indra; Pankaj Karande
Journal:  Pharmaceutics       Date:  2022-01-28       Impact factor: 6.321

3.  Porous Se@SiO2 Nanoparticles Enhance Wound Healing by ROS-PI3K/Akt Pathway in Dermal Fibroblasts and Reduce Scar Formation.

Authors:  Bo-Yu Yang; Zhi-Yuan Zhou; Shi-Yun Liu; Ming-Jun Shi; Xi-Jian Liu; Tian-Ming Cheng; Guo-Ying Deng; Ye Tian; Jian Song; Xuan-Hao Li
Journal:  Front Bioeng Biotechnol       Date:  2022-03-21

Review 4.  Impaired Wound Healing, Fibrosis, and Cancer: The Paradigm of Recessive Dystrophic Epidermolysis Bullosa.

Authors:  Grace Tartaglia; Qingqing Cao; Zachary M Padron; Andrew P South
Journal:  Int J Mol Sci       Date:  2021-05-12       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.